Skip to main content
BRKR
NASDAQ Life Sciences

Bruker Q3 EPS Jumps 24% on Margin Expansion; FY26 Outlook Reconfirmed

Tom Rudovsky · Reported by BusinessWire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$56.25
Mkt Cap
$8.608B
52W Low
$32.365
52W High
$66.981
52W Position info
74% above low
Off High info
16% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

BRKR sits 74% above its 52-week low of $32.365 on elevated volume (2.0× avg).

Summary

Bruker posted Q3 revenue of $874.0M, up 1.6% yoy but only 0.7% organically, while non-GAAP EPS rose 24.4% to $0.56 as non-GAAP operating margin expanded to 16.3% from 12.3%. The headline number is the margin and cost story, not growth: BSI organic revenue actually fell 0.4%, offset by BEST's 11.8% organic gain. GAAP results were ugly — a $174.5M non-cash goodwill impairment drove a $91.0M operating loss, a $111.8M loss and $(0.81) diluted EPS — but that is excluded from the non-GAAP figures traders focus on. Management reconfirmed FY26 revenue of $3.52-$3.56B and non-GAAP EPS of $2.10-$2.15, only tweaking FX to neutral from a prior 0.5% tailwind, and guided to 2026 organic revenue growth of 1% to 2%, and cited a fifth straight quarter of BSI book-to-bill above 1 plus mid-single-digit organic bookings and backlog growth. The 8:30 am ET call is the next checkpoint, where the FY27 double-digit EPS growth claim and the weak organic top line will get pressed.

At the time of this announcement, BRKR was trading at $56.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.6B. The 52-week trading range was $32.37 to $66.98. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

BRKR - Latest Insights

BRKR
Nov 05, 2026, 4:02 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $58.06
Real-time Price: $64.22 info
Change: +$6.16 (+11%) info
Market Cap: $9.807B info
BRKR
Nov 04, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $56.25
Real-time Price: $64.22 info
Change: +$7.97 (+14%) info
Market Cap: $9.807B info
BRKR
Aug 05, 2026, 4:24 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $52.58
Real-time Price: $64.22 info
Change: +$11.64 (+22%) info
Market Cap: $9.807B info
BRKR
Aug 04, 2026, 7:05 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $59.00
Real-time Price: $64.22 info
Change: +$5.22 (+9%) info
Market Cap: $9.807B info
BRKR
Aug 04, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $59.00
Real-time Price: $64.22 info
Change: +$5.22 (+9%) info
Market Cap: $9.807B info